Diabetic cardiomyopathy: a brief summary on lipid toxicity

Related Experiment Video

Updated: Aug 22, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

263

Jiahan Ke1, Jianan Pan1, Hao Lin1

  • 1Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

ESC Heart Failure
|November 12, 2022
PubMed

Insights

Diabetic cardiomyopathy (DCM) involves heart dysfunction from diabetes. This review explores how lipid toxicity in diabetic hearts contributes to DCM and discusses potential therapies.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Molecular Biology

Background:

  • Diabetes mellitus (DM) is a global epidemic, with cardiovascular diseases causing most deaths in diabetic patients.
  • Diabetic cardiomyopathy (DCM) is heart dysfunction specifically due to DM, independent of hypertension or coronary artery disease.
  • Obesity and insulin resistance in type 2 DM lead to dyslipidemia and lipotoxicity, affecting the heart.

Purpose of the Study:

  • To summarize recent discoveries on lipid-induced cardiac toxicity in diabetic hearts.
  • To discuss the mechanisms by which lipotoxicity alters cardiac function in DCM.
  • To review current therapies and controversies in managing clinical DCM.

Main Methods:

  • Literature review of recent scientific progress in understanding DCM.
  • Analysis of proposed mechanisms underlying lipid-induced cardiac toxicity.
  • Synthesis of information on therapeutic strategies and ongoing debates in DCM.

Main Results:

  • Lipotoxicity is a key factor in the development of cardiac dysfunction in diabetic cardiomyopathy.
  • Understanding the precise mechanisms of lipotoxicity in the diabetic heart is still evolving.
  • Various therapeutic approaches are being explored, but controversies remain.

Conclusions:

  • Lipid-induced cardiac toxicity significantly contributes to diabetic cardiomyopathy.
  • Further research is needed to fully elucidate the mechanisms and optimize therapies for DCM.
  • Addressing lipotoxicity is crucial for managing heart complications in diabetic patients.

Keywords:
Cardiovascular diseasesDiabetes mellitusDiabetic cardiomyopathyLipotoxicity

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

717
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.2K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.1K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
22
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
18